TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science October 28, 1994